These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 3870143)

  • 1. Principia of cancer therapy. XI. Prostaglandin D2 induces redifferentiation of M1 leukemia cells in vitro irrespective of bestatin.
    Okuyama S; Mishina H
    Sci Rep Res Inst Tohoku Univ Med; 1985 Dec; 32(1-4):35-8. PubMed ID: 3870143
    [No Abstract]   [Full Text] [Related]  

  • 2. Principia of cancer therapy. X. Prostaglandin D2 triggers redifferentiation of the bestatin-treated breast cancer cells in vitro.
    Okuyama S; Mishina H
    Sci Rep Res Inst Tohoku Univ Med; 1985 Dec; 32(1-4):31-4. PubMed ID: 3870142
    [No Abstract]   [Full Text] [Related]  

  • 3. Redifferentiation of cancer cells: bestatin, estradiol, and prostaglandin D2.
    Okuyama S; Mishina H; Maki T
    Ann N Y Acad Sci; 1985; 459():293-307. PubMed ID: 3868328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antineoplastic action of prostaglandin D2--effect of PGD2 on proliferation of L1210 leukemic cells in culture].
    Fukushima M; Kato T; Ota K
    Gan To Kagaku Ryoho; 1982 Jan; 9(1):159-60. PubMed ID: 6964030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diminished sensitivity of platelet aggregation to prostaglandin D2 in patients with myeloproliferative disorders and in patients with acute leukemia.
    Wong P; Fujioka S; Yoshida S
    Nihon Ketsueki Gakkai Zasshi; 1985 Feb; 48(1):147-54. PubMed ID: 3890456
    [No Abstract]   [Full Text] [Related]  

  • 6. [Differentiation induction and potentiation of chemotherapy by PGE1 infusion in patients with neuroblastoma--effect of PGE1 on metastatic potential of neuroblastoma].
    Imashuku S; Esumi N; Todo S; Nakajima F
    Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):775-80. PubMed ID: 6585182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effects of neuroendocrine hormones on human ovarian cancer cell proliferation in vitro.
    Kikuchi Y; Kita T; Miyauchi M; Oomori K; Kizawa I; Iwano I; Kato K
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Sep; 39(9):1653-4. PubMed ID: 3479504
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostaglandin D2 induces sleep when infused into the cerebral ventricle of conscious monkeys.
    Hayaishi O; Ueno R; Onoe H; Osama H; Fujita I; Nishino H; Oomura Y
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():946-8. PubMed ID: 2960208
    [No Abstract]   [Full Text] [Related]  

  • 9. Prostaglandins and metastasis.
    Stringfellow DA
    Symp Fundam Cancer Res; 1983; 36():123-31. PubMed ID: 6206537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of differentiation-stimulating factor for murine leukemic myeloblast line by monocytic cells stimulated by a nonpyrogenic muramyl dipeptide derivative.
    Parant M; Vinit MA; Damais C; Riveau G; Chedid L
    Exp Hematol; 1985 Mar; 13(3):221-8. PubMed ID: 3872225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active transport and cellular accumulation of cyclopentenone prostaglandins: a mechanism of prostaglandin-induced growth inhibition.
    Narumiya S; Fukushima M
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():972-5. PubMed ID: 2960214
    [No Abstract]   [Full Text] [Related]  

  • 12. Specific inhibition by prostaglandin D2 and its metabolites of lysozyme synthesis in mouse macrophage-like cell line, Mm-1.
    Kasukabe T; Honma Y; Hozumi M
    Biochim Biophys Acta; 1985 Mar; 844(3):330-6. PubMed ID: 3855662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory control of the proliferation ad differentiation of normal and leukemia cells.
    Metcalf D
    Natl Cancer Inst Monogr; 1982; 60():123-31. PubMed ID: 6981771
    [No Abstract]   [Full Text] [Related]  

  • 14. In vivo effects of prostaglandins on human retinoblastoma cells in nude mice.
    Nakamura M; Fujino Y; Mochizuki M; Minoda K; Masuda K
    Jpn J Ophthalmol; 1987; 31(4):608-20. PubMed ID: 3482290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin D2: a neuromodulator.
    Hayaishi O
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():333-7. PubMed ID: 6221610
    [No Abstract]   [Full Text] [Related]  

  • 16. Preferential generation of prostaglandin D2 by rat and human mast cells.
    Lewis RA; Holgate ST; Roberts LJ; Oates JA; Austen KF
    Kroc Found Ser; 1981; 14():239-54. PubMed ID: 6796654
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on the mechanisms of action of the immunomodulator Bestatin in various screening test systems.
    Schorlemmer HU; Bosslet K; Dickneite G; Lüben G; Sedlacek HH
    Behring Inst Mitt; 1984 May; (74):157-73. PubMed ID: 6383322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of prostaglandin (delta 12-PGJ2) on host immunity--an experimental study].
    Matsuura H; Imaya H
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1936-7. PubMed ID: 3592721
    [No Abstract]   [Full Text] [Related]  

  • 19. Prostaglandin D2: a cerebral sleep-regulating substance in rats.
    Ueno R; Hayaishi O; Inoué S; Nakayama T
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():581-3. PubMed ID: 2936173
    [No Abstract]   [Full Text] [Related]  

  • 20. Prostaglandin D2 mediated specific increase in rat brain serotonin.
    Bhattacharya SK; Goodall WM; Brumleve SJ; Parmar SS
    Proc West Pharmacol Soc; 1985; 28():217-20. PubMed ID: 3865228
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.